The presence of IL2 within the tumor through intratumoral IC may have a crucial role in driving this proposed T-dependent antibody response, as IL2 has been shown to be critical for CD40-mediated activation of naïve B cells by CD4 T cells (30). The gene discussed is IL2; the disease is neoplasm.